Caroline Baumal, M.D.

Caroline R. Baumal, MD is a Professor of Ophthalmology at Tufts Medical Center and co-director of the retina service and medical retina fellowship at New England Eye Center in Boston, MA. She specializes in medical and surgical diseases of the retina and vitreous. Her research interests include novel retinal imaging and drug development, which are a continuation from her research background with the prototype OCT and working with drug implants and photodynamic therapy. Her clinical interests include age-related macular degeneration, diabetic retinopathy, retinal circulatory disorders, complex vitreoretinal surgery, and retinopathy of prematurity (ROP).

Dr. Baumal completed medical school and ophthalmology residency at the University of Toronto after undergraduate studies at McGill University. She completed two fellowships: one at New England Eye Center, Boston in Medical Retina and Lasers and another in Vitreoretinal Diseases and Surgery at Wills Eye Hospital in Philadelphia. Dr. Baumal is Board Certified by the American Board of Ophthalmology. She has received multiple awards from various societies including the American Academy of Ophthalmology, The American Society of Retinal Surgeons, The Retinal Hall of Fame, the Donald J. Gass Beacon of Sight Award from the Florida Ophthalmologic Society, the ASRS Crystal Apple award and was recently awarded the Lifetime Achievement award from the Vit-Buckle Society. She is on the editorial board for Retina Cases and Brief Reports and Ophthalmic Surgery, Lasers, and Imaging (OSLI) Retina. Dr. Baumal has authored over 170 publications, 33 book chapters on retinal diseases and edited the book Treatment of Diabetic Retinopathy. She is actively involved in mentoring and teaching vitreoretinal fellows and residents and was previously Director of Education and the Residency program at New England Eye Center.

David Boyer, M.D.

David S. Boyer, M.D., is a board-certified ophthalmologist specializing in the treatment of retinal and vitreous diseases. He is a Senior Partner at Retina-Vitreous Associates Medical Group. Dr. Boyer earned his medical degree at Chicago Medical School, completed his internship and residency at the University of Southern California/Los Angeles County Medical Center, and completed his fellowship in retinal surgery at the Wills Eye Hospital in Philadelphia. Dr. Boyer is a clinical professor of ophthalmology at the Keck School of Medicine of the University of Southern California and has an extensive research background. He is one of the leading retinal clinical researchers in the country for new treatments in macular degeneration and diabetic macular edema. Dr. Boyer is a widely-published author and avid lecturer who lectures internationally on retinal research and innovative approaches to the treatment of retinal disease. He has authored and co-authored numerous works in peer-reviewed journals and has served as a reviewer for ophthalmology and diabetes medical publications, including Archives of Ophthalmology, American Journal of Ophthalmology, and Ophthalmology.

David Brown, M.D., F.A.C.S

David Brown, M.D. F.A.C.S. is the director of research at Retina Consultants of Texas, chair of the Medical Leadership Board of Retina Consultants of America (RCA), and a member of the RCA board of directors. Additionally, Dr. Brown is a Clinical Professor of Ophthalmology at Baylor College of Medicine, vice-chair for research for Houston Methodist Hospital, and is a member of NASA’s research and clinical advisory panel. Dr. Brown graduated from Baylor College of Medicine with highest honors and completed ophthalmology and retina training at the University of Iowa. He was a Thomas Heed Fellow, a Hermann Knapp Fellow, and was awarded the Ron Michels Fellowship award presented to the top retinal surgery fellow in the US in 1994.

Dr. Brown is a renowned leader in the retina and has published over 500 national meeting presentations, abstracts, and scientific papers, including many of the primary papers that established the use of anti-VEGF agents for AMD, retinal vein occlusion, and diabetic retinopathy (DR). He serves as a peer-reviewer for 8 ophthalmology journals and has authored 9 book chapters. Dr. Brown is an investigator in Ocuphire’s ZETA-1 Phase 2 clinical trial evaluating the safety and efficacy of oral APX3330 in patients with diabetic retinopathy.

Jeffrey Heier, M.D.

Dr. Heier is the Co-President, Medical Director, Director of the Vitreoretinal Service, and Director of Retina Research at Ophthalmic Consultants of Boston (OCB), one of the largest and most prestigious multi-specialty ophthalmology practices in the United States. He is also on the Executive Board of the Retina Society and the Executive Committee of the American Society of Retina Specialists. He is the Past President of the New England Ophthalmological Society, and is a member of the Macula Society. Dr. Heier has received several awards from the American Academy of Ophthalmology, including the Senior Achievement Award in 2010, the Secretariat Award in 2007, and the Honor Award in 2003. He is also the recipient of the Honor Award and Senior Honor Award from the American Society of Retina Specialists. Dr. Heier is one of the leading retinal clinical researchers in the country for new treatments in exudative and non-exudative macular degeneration, diabetic macular edema, venous occlusive disease, vitreoretinal surgical techniques and instrumentation, and diagnostic imaging of the retina. He is a scientific advisor to several biotechnical or pharmaceutical companies, lectures nationally and internationally, and has authored numerous, peer-reviewed works. Dr. Heier received his medical degree from Boston University, did an internship and residency at Fitzsimons Army Medical Center, and a vitreoretinal fellowship at OCB/Tufts School of Medicine. Dr. Heier served as a physician in a Combat Support Hospital in the Persian Gulf War, where he was awarded a Bronze Star.

David Lally, M.D.

David Lally, M.D. F.A.S.R.S. is a retina surgeon at Baystate Medical Center, an Assistant Professor of Ophthalmology at the University of Massachusetts Medical School-Baystate, and the director of the Retina Research Institute at New England Retina Consultants. Dr. Lally graduated from Vanderbilt University and received a medical degree from Jefferson Medical College. He completed ophthalmology residency at the Wills Eye Hospital in Philadelphia followed by a vitreoretinal fellowship at Tufts/New England Eye Center and Ophthalmic Consultants of Boston. He is an a is an active member of the American Society of Retina Specialists with the Fellow of the American Society of Retina Specialist (FASRS) award designation.

Dr. Lally’s work has been published in over 25 articles in peer-reviewed ophthalmic journals, and he has delivered over 25 presentations at national meetings. Dr. Lally is part of several clinical trial steering committees and an exceptional recruiter as principal investigator in numerous retina clinical trials. Dr. Lally is an investigator in Ocuphire’s ZETA-1 Phase 2 clinical trial.

Peter K. Kaiser, M.D.

Peter K. Kaiser, M.D., is a clinical research expert, serving as Study Chairman of 5 major, multi-center, international clinical trials, and principal investigator in numerous studies for AMD, DR, and other retinal disorders. He is the founder and director of the Digital Optical Coherence Tomography Reading Center (DOCTR), Editor-in-Chief of Retinal Physician, Associate Editor of International Ophthalmology Clinics, and serves on the editorial boards of Retina, Retina Today, and Ocular Surgery News. He is a National Institute of Health (NIH) funded investigator, leading a team involved in the evaluation of vascular biology in age-related macular degeneration and diabetic retinopathy. Dr. Kaiser serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences. He is a major contributor to the medical literature having authored 7 textbooks, and more than 250 peer-reviewed papers, and has been recognized by the American Academy of Ophthalmology and American Society of Retina Specialists with Senior Achievement Awards and is listed as one of the “Best Doctors in America.” Dr. Kaiser graduated magna cum laude with Highest Honors from Harvard College and Harvard Medical School. He completed an ophthalmology residency at the Massachusetts Eye and Ear Infirmary, and a vitreoretinal fellowship at Bascom Palmer Eye Institute before joining the vitreoretinal department of the Cole Eye Institute, Cleveland, Ohio.    

Arshad M. Khanani, MD, MA, FASRS

Arshad M. Khanani, MD, MA, FASRS is a Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates and Clinical Associate Professor at the University of Nevada, Reno School of Medicine. Dr. Khanani founded the clinical research department at Sierra Eye Associates, which is now one of the leading clinical research centers in the country. He has served as a principal investigator for over 120 clinical trials and has been a top enroller in the country for multiple Phase 1-3 trials. Dr. Khanani also serves as a member of numerous national and international clinical trial steering committees as well as scientific advisory boards with the goal of bringing new treatment options for patients with retinal diseases. He has authored over 100 publications in prominent ophthalmology journals. Dr. Khanani is an elected member of the Macula Society, Retina Society and has received numerous awards of distinction.  In 2019, he received the Nevada Business Magazine Healthcare Heroes Physician of the Year award for his continued dedication to the field of ophthalmology. He has received the Senior Honor Award from the American Society of Retina Specialists (ASRS) and was also awarded the prestigious ASRS Presidents’ Young Investigator Award in 2021.

Anat Lowenstein, MD, MHA

Anat Loewenstein, MD, Professor of Ophthalmology, Vice Dean of the Faculty of Medicine, and Sidney Fox Chair of Ophthalmology at the Sackler Faculty of Medicine at the Tel Aviv University, Chairman of the Department of Ophthalmology, Tel Aviv Medical Center. Completed residency in the Department of Ophthalmology at the Tel Aviv Medical Center, fellowship in vitreoretina at the Wilmer Institute, Johns Hopkins University Hospital in Baltimore. Is Chairman of the Department of Ophthalmology at the Tel Aviv Medical Center since 2000. Completed a Master of Health Administration degree at the Tel Aviv University Business School. Is involved in the development of multiple innovative efforts, was the leader behind the development of novel technology for early detection of macular degeneration, as well as recently, the development of automated technology for detection of retinal disease activity and the development of augmented virtual reality to replace the operating microscope. Published more than 380 papers in peer reviewed journals, and contributed multiple chapters to ophthalmology textbooks. Has multiple roles in most prominent retina societies. Is active at most international retina meetings and is an invited speaker in most. Serves as the Editor of the Journal Case Reports in Ophthalmology, is an associate Serves as the chair of the Ministry of Health’s ethics committee and is a member of the National Council of Surgery and anesthesia. Received multiple international awards in most prestigious societies.

Carl D. Regillo, MD, FASRS

Dr. Carl D. Regillo is Professor of Ophthalmology at Thomas Jefferson University, Chief of the Retina Service of Wills Eye Hospital and Founder of the Wills Eye Clinical Retina Research Unit in Philadelphia.  He received his medical degree from Harvard Medical School and performed his ophthalmology residency and vitreoretinal fellowship at Wills Eye Hospital.  He has authored over 300 publications along with over 50 book chapters and 9 major books.  He has been an investigator on numerous major clinical trials developing new medical and surgical treatments for retinal disorders such as macular degeneration and diabetic retinopathy.   He is invited to lecture worldwide and serves on the scientific editorial board for several top ophthalmology peer-reviewed journals.  As a recognized leader in the field, he is a recipient of the many local, national, and international awards including American Academy of Ophthalmology Achievement, Senior Achievement, Secretariat, and Lifetime Achievement Awards and the American Society of Retinal Specialists Honor, Senior Honor, Presidential, and Founders Awards.  He was charter inductee of the Retina Hall of Fame and named in the Ophthalmologist Power List of the top 100 most influential ophthalmologists in the world.  He was also listed among the top 150 ophthalmologists in the US by Newsweek.

Rishi P. Singh, MD

Dr. Rishi P. Singh MD is a staff surgeon and vice-president/chief medical offier of Clevealnd Clinic Martin Health in Stuart Florida, and Professor of Ophthalmology at the Lerner College of Medicine in Cleveland Ohio. He received his bachelor’s and medical degrees from Boston University and completed his residency at the Massachusetts Eye and Infirmary Harvard Combined Program in Boston, Massachusetts. Dr. Singh then completed a medical and surgical fellowship at the Cole Eye Institute in Cleveland, Ohio.

He specializes in the treatment of medical and surgical retinal disease such as diabetic retinopathy, retinal detachment, and age-related macular degeneration. Dr. Singh has authored more than 250 peer reviewed publications, books, and book chapters and serves as the principal investigator of numerous national clinical trials advancing the treatment of retinal disease.

Charles C. Wykoff, MD, PhD, FACS, FASRS

Dr. Charles C. Wykoff is a board-certified Medical and Surgical Retina Specialist and ophthalmologist with Retina Consultants of Texas (RCTX). Leading a top international research facility for vitreoretinal diseases, Dr. Wykoff serves as Director of Research at RCTX and Chairman of the Research and Clinical Trials Committee, Retina Consultants of America. He is also Professor of Clinical Ophthalmology and Deputy Chair of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital.

 Dr Wykoff is a member of the NEI Audacious Goals Steering Committee and has been awarded multiple Achievement, Honor and Senior Honor Awards including the ASRS Young Investigator and the AAO Secretariat Awards.